Myopic Choroidal Neovascularization: Diagnosis and Treatment Update

被引：0
|
作者：
Mariana R. Thorell
Raquel Goldhardt
机构：
[1] Royal Liverpool University Hospital,Department of Ophthalmology St. Paul’s Eye Unit
[2] University of Miami Miller School of Medicine,Department of Ophthalmology, Bascom Palmer Eye Institute
[3] Miami Veterans Administration Medical Center,undefined
来源：
Current Ophthalmology Reports | 2019年 / 7卷
关键词：
Pathological myopia; Degenerative myopia; Choroidal neovascularization; Optical coherence tomography; Vascular endothelial growth factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 65
页数：6
相关论文
共 50 条
  • [21] Differential diagnosis of myopic choroidal neovascularization (mCNV): insights from multimodal imaging and treatment implications
    Feo, Alessandro
    De Simone, Luca
    Cimino, Luca
    Angi, Martina
    Romano, Mario R.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (07) : 2005 - 2026
  • [22] Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
    Wang, Jia-Kang
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Chen, Yen-Ting
    Chang, Chin-Wei
    Chen, Fang-Ting
    Hsu, Yung-Ray
    Chen, Yun-Ju
    SCIENTIFIC REPORTS, 2018, 8
  • [23] Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
    Jia-Kang Wang
    Tzu-Lun Huang
    Pei-Yao Chang
    Yen-Ting Chen
    Chin-Wei Chang
    Fang-Ting Chen
    Yung-Ray Hsu
    Yun-Ju Chen
    Scientific Reports, 8
  • [24] Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization
    Mandal, S.
    Venkatesh, P.
    Sampangi, R.
    Garg, S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (04) : 620 - 626
  • [25] Treatment of myopic choroidal neovascularization: Recommendations of the Federation France Macula
    Leveziel, N.
    Maftouhi, M. Quaranta-El
    Lalloum, F.
    Souied, E.
    Cohen, S. Y.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2014, 37 (04): : 320 - 328
  • [26] INTRAVITREAL RANIBIZUMAB VERSUS BEVACIZUMAB FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
    Iacono, Pierluigi
    Parodi, Maurizio Battaglia
    Papayannis, Alessandro
    Kontadakis, Stylianos
    Sheth, Saumil
    Cascavilla, Maria Lucia
    Bandello, Francesco
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (08): : 1539 - 1546
  • [27] ECONOMIC EVALUATION OF RANIBUZUMAB FOR THE TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN CANADA
    Lee, A.
    Zaour, N.
    Becker, D. L.
    Leteneux, C.
    Barbeau, M.
    VALUE IN HEALTH, 2013, 16 (07) : A506 - A506
  • [28] Intravitreal aflibercept for myopic choroidal neovascularization
    Pece, Alfredo
    Milani, Paolo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (12) : 2327 - 2332
  • [29] Intravitreal aflibercept for myopic choroidal neovascularization
    Pece, Alfredo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (07) : 1435 - 1435
  • [30] Myopic choroidal neovascularization: To load or not to load
    Cornish, Elisa E.
    Gillies, Mark C.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 (02): : 161 - 162
12345